BULLFROG AI HOLDINGS, INC. Restricted Cash, Current
BULLFROG AI HOLDINGS, INC. (BFRG) had Restricted Cash, Current of $100.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2026-08-14
- 2026-06-30: Restricted Cash, Current $100.00K.
- 2026-03-31: Restricted Cash, Current $100.00K.
- 2025-12-31: Restricted Cash, Current $100.00K.
- 2025-09-30: Restricted Cash, Current $100.00K.
| Period end | Restricted Cash, Current |
|---|---|
| 2026-06-30 | $100.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $100.00K 10-K · filed 2026-03-19 |
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $100.00K 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |